Terumo Corp. Stock Hits Day High with Strong 5.3% Intraday Surge

Terumo Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable uptick in its stock performance today, gaining 5.3% as of October 7, 2025. The stock reached an intraday high of JPY 2,587.00, reflecting a positive shift in market sentiment.
In terms of performance metrics, Terumo Corp. has shown a 6.46% increase over the past week, slightly outperforming the Japan Nikkei 225, which rose by 6.44%. However, the company has faced challenges over the longer term, with a year-to-date decline of 15.99% compared to the Nikkei's gain of 20.18%. Over the past three years, Terumo has underperformed the benchmark index, with a significant drop of 40.67%.

Despite these challenges, Terumo Corp. maintains a strong financial foundation, characterized by a low debt-to-equity ratio of -0.03 and a healthy EBIT to interest ratio of 36.60. The company has demonstrated consistent net sales growth at an annual rate of 10.50%, indicating robust long-term fundamentals. With a market capitalization of JPY 3,916,821 million, Terumo continues to be a significant entity in its industry.